Polymalic acid-based nanobiopolymer provides efficient systemic breast cancer treatment by inhibiting both HER2/neu receptor synthesis and activity.
Inoue S, Ding H, Portilla-Arias J, Hu J, Konda B, Fujita M, Espinoza A, Suhane S, Riley M, Gates M, Patil R, Penichet ML, Ljubimov AV, Black KL, Holler E, Ljubimova JY.
Inoue S, et al.
Cancer Res. 2011 Feb 15;71(4):1454-64. doi: 10.1158/0008-5472.CAN-10-3093. Epub 2011 Feb 8.
Cancer Res. 2011.
PMID: 21303974
Free PMC article.